Henry Han Heart_SCCT Renée Bullock-Palmer MD FACC FAHA FASNC FASE FSCCT Marco Guglielmo MD, FEACVI, FSCCT Mamas A. Mamas Ritu Thamman MD Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦 John P Erwin III MD MBA MACC (#BigPoppy ) MIЯVΛƬ #IC Aaysha Cader Erik Rafflenbeul rafavidalperez ALEXANDRU MISCHIE #persistent_ductus_arteriousus tubular type.

Joint British Society consensus recommendations for magnetic resonance imaging for patients with cardiac implantable electronic devices heart.bmj.com/content/early/… Broad collaboration to provide guidance to patients and staff involved in #MRI with #pacemakers and #ICDs.

⁦St. Mark's Hospital⁩ ⁦Dr. John Day⁩ ⁦Vamsee Yaganti⁩ ⁦Nischala Nannapaneni⁩ mountain division cardiovascular symposium with current cardiovascular updates. Great sessions. We are also celebrating 150 years of st marks.

Athletic Activity for Patients With Hypertrophic Cardiomyopathy and Other Inherited Cardiovascular Diseases: JACC Focus Seminar 3/4 | Journal of the American College of Cardiology jacc.org/doi/10.1016/j.…

Oktoberfest 2022 is here 🍻🫀🩻 • every Wednesday in October • ⏰ 12 pm (MT) #cardiovascular #MedTwitter tinyurl.com/Oktoberfest202… Angela Washenko, BSN, RN 🇺🇸🇺🇦 Stavros George Drakos Poorna Nalabothu Anna Ciullo, MD Jason P. Glotzbach, MD U of U Cardiovascular Medicine UofUCVSL University of Utah Department of Internal Medicine University of Utah Health University of Utah GME Office University of Utah Vascular Surgery

What an impressive talk on Heart Failure: How is it different in Women? Poorna Nalabothu gave a very informative talk emphasizing the important questions on practice gaps.

I’m so excited for this years #UCARS23 We will have ICCAC session Marisca Nelson # Erin Grimm speaking on “How to Follow & Manage Candidates for Recovery.” Jennifer Hajj, RN Sarah E Schroeder, PhD, ACNP-BC, MSN RN, AACC Krystina Chickerillo MSN, FNP-BC Camila Vargas Daphenie Poorna Nalabothu @JacobMD11 Manreet Kanwar Emma Birks

SGLT2i for Chronic Heart Failure: The Ultimate Solution? onlinelibrary.wiley.com/doi/abs/10.100… #HeartFailure #SGLT2i #CardioEd European Society of Cardiology Journals HFAPresident

Interstitial fibrosis is not the only histological factor in atrial structural remodelling; ⬆️ in intercellular space preceding fibrosis, degeneration of the myocardial parenchyma ⬇️ in cardiomyocyte number are also important histological factors. academic.oup.com/eurheartj/adva…

Excited to hear from the speakers about cardiovascular updates.

🔴Pulmonary hypertension associated with left heart disease ⤵️ Brand new Staging of PH 🔹PH ass w/ left heart disease is the most common cause of PH. Propose a brand new staging of PH in this context. bit.ly/4fc5p1V

🔴 Vasopressors and Inotropes #CardioTwitter #Cardiology #surgery #anesthesiology #MedEd #CriticalCare #FOAMcc #FOAMed #surgery #clinical #clinic #orthotwitter

Join CardioNerds Shazli Khan and me for live updates during the virtual Late Breaking Clinical Research sessions at #HFSA2024! Some of trials represented include: ❤️STEP-HFpEF ❤️FINEARTS-HF ❤️HELIOS-B ❤️SEQUOIA-HCM ❤️EMBARK HFpEF ❤️ARIES-HM3 🔗 hfsa.org/asm/hurricane-…

Wonderful #ACCWIC Leadership Conference today with the WIC Council #ACCWIC Jennifer Co-Vu, MD, FACC, FAAP, FASE Estefania Oliveros MD🫀 Dr. Sarah (Rosine) Rosanel, MD, FACC Ambreen Mohamed, MD, FACC Sabrina Islam, MD, MPH Lori Daniels Sneha Nandy Amanda W. Cai, MD Nicole J Sutton MD Arooj Khan Kamala Tamirisa MD Toniya Singh MD FACC

#ACCLegConf Advocacy is the antidote for burnout. Recognize the gap. Identify the challenges. Advocate for our patient’s.

#ACCLegConf .excited to hear from physician leaders and congress. Incorporating AI in EHR, remote monitoring of patients and many more opportunities .

Are you interested in the young field of #CriticalCareCardiology? What do you think the current and future pathways look like? Read our work led by Andrea Elliott and David M. Dudzinski MD published in JACC Journals today - authors.elsevier.com/a/1js3M_GjkRPS…. Brown University Health The Warren Alpert Medical School

Next up in #HFSA2024, we have EMBARK-HFpEF, an open label non-randomized study, exploring myosin inhibition with mavacamten in HFpEF presented by Sanjiv J. Shah, MD! Early results look promising with these key takeaways: ⭐️27% ⬇️NTproBNP ⭐️20% ⬇️Troponin ⭐️42% ⬆️ NYHA class 🧵(1/2)

🔴 Invasive haemodynamic assessment in HFpEF #Cardiology #CardioEd #FOAMed European Society of Cardiology Journals

STATE-OF-THE-ART REVIEW IN EHJ Editor-in-Chief 🫀#whycmr in Mitral Valve Disease.🫀 Training videos included! 📽️ academic.oup.com/eurheartj/arti… Seth Uretsky Society for Cardiovascular Magnetic Resonance BSCMR WHYCMR-BOT Vass Vassiliou Manish Motwani Charlotte Manisty Chetan Shenoy Amit R. Patel Julia Grapsa MD, PhD European Society of Cardiology European Society of Cardiology Journals Dipan J. Shah, MD